These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21059895)

  • 1. Noncytotoxic inhibition of cytomegalovirus replication through NK cell protease granzyme M-mediated cleavage of viral phosphoprotein 71.
    van Domselaar R; Philippen LE; Quadir R; Wiertz EJ; Kummer JA; Bovenschen N
    J Immunol; 2010 Dec; 185(12):7605-13. PubMed ID: 21059895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated granzyme M-expressing lymphocytes during cytomegalovirus latency and reactivation after allogeneic stem cell transplantation.
    Bovenschen N; Spijkers SN; Wensink AC; Schellens IM; van Domselaar R; van Baarle D
    Clin Immunol; 2014 Jan; 150(1):1-11. PubMed ID: 24316590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer cell proteases can target viral immediate-early proteins to control human cytomegalovirus infection in a noncytotoxic manner.
    Shan L; Li S; Meeldijk J; Blijenberg B; Hendriks A; van Boxtel KJWM; van den Berg SPH; Groves IJ; Potts M; Svrlanska A; Stamminger T; Wills MR; Bovenschen N
    PLoS Pathog; 2020 Apr; 16(4):e1008426. PubMed ID: 32282833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytotoxic protease granzyme M is expressed by lymphocytes of both the innate and adaptive immune system.
    de Koning PJ; Tesselaar K; Bovenschen N; Colak S; Quadir R; Volman TJ; Kummer JA
    Mol Immunol; 2010 Jan; 47(4):903-11. PubMed ID: 19896187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells.
    Hwang J; Kalejta RF
    Virology; 2007 Oct; 367(2):334-8. PubMed ID: 17590404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.
    Borysiewicz LK; Rodgers B; Morris S; Graham S; Sissons JG
    J Immunol; 1985 Apr; 134(4):2695-701. PubMed ID: 2579152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granzyme M targets host cell hnRNP K that is essential for human cytomegalovirus replication.
    van Domselaar R; de Poot SA; Remmerswaal EB; Lai KW; ten Berge IJ; Bovenschen N
    Cell Death Differ; 2013 Mar; 20(3):419-29. PubMed ID: 23099853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro.
    Saffert RT; Kalejta RF
    J Virol; 2007 Sep; 81(17):9109-20. PubMed ID: 17596307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.
    Cederarv M; Söderberg-Nauclér C; Odeberg J
    Immunobiology; 2009; 214(5):331-41. PubMed ID: 19152985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cell protease granzyme M targets alpha-tubulin and disorganizes the microtubule network.
    Bovenschen N; de Koning PJ; Quadir R; Broekhuizen R; Damen JM; Froelich CJ; Slijper M; Kummer JA
    J Immunol; 2008 Jun; 180(12):8184-91. PubMed ID: 18523284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state.
    Andrade F
    Immunol Rev; 2010 May; 235(1):128-46. PubMed ID: 20536560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression.
    Saffert RT; Kalejta RF
    J Virol; 2006 Apr; 80(8):3863-71. PubMed ID: 16571803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of human pancreatic β cells for cytomegalovirus infection and the effects on cellular immunogenicity.
    Smelt MJ; Faas MM; de Haan BJ; Draijer C; Hugenholtz GC; de Haan A; Engelse MA; de Koning EJ; de Vos P
    Pancreas; 2012 Jan; 41(1):39-49. PubMed ID: 22158077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UL40-mediated NK evasion during productive infection with human cytomegalovirus.
    Wang EC; McSharry B; Retiere C; Tomasec P; Williams S; Borysiewicz LK; Braud VM; Wilkinson GW
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7570-5. PubMed ID: 12032324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein.
    Welte SA; Sinzger C; Lutz SZ; Singh-Jasuja H; Sampaio KL; Eknigk U; Rammensee HG; Steinle A
    Eur J Immunol; 2003 Jan; 33(1):194-203. PubMed ID: 12594848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.
    Farrell HE; Vally H; Lynch DM; Fleming P; Shellam GR; Scalzo AA; Davis-Poynter NJ
    Nature; 1997 Apr; 386(6624):510-4. PubMed ID: 9087412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins.
    Odeberg J; Browne H; Metkar S; Froelich CJ; Brandén L; Cosman D; Söderberg-Nauclér C
    J Virol; 2003 Apr; 77(8):4539-45. PubMed ID: 12663760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing.
    Scott GB; Bowles PA; Wilson EB; Meade JL; Low BC; Davison A; Blair GE; Cook GP
    Biochem J; 2010 Nov; 431(3):423-31. PubMed ID: 20704564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
    Rölle A; Olweus J
    APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral evasion of NK-cell activation.
    Rajagopalan S; Long EO
    Trends Immunol; 2005 Aug; 26(8):403-5. PubMed ID: 15979408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.